GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioteque Corp (ROCO:4107) » Definitions » Price-to-Owner-Earnings

Bioteque (ROCO:4107) Price-to-Owner-Earnings : 22.01 (As of Jun. 24, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Bioteque Price-to-Owner-Earnings?

As of today (2024-06-24), Bioteque's share price is NT$129.00. Bioteque's Owner Earnings per Share (TTM) ended in Mar. 2024 was NT$5.86. It's Price-to-Owner-Earnings for today is 22.01.


The historical rank and industry rank for Bioteque's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:4107' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.73   Med: 24.92   Max: 47
Current: 22.27

During the past 13 years, the highest Price-to-Owner-Earnings of Bioteque was 47.00. The lowest was 11.73. And the median was 24.92.


ROCO:4107's Price-to-Owner-Earnings is ranked better than
62.46% of 285 companies
in the Medical Devices & Instruments industry
Industry Median: 31.42 vs ROCO:4107: 22.27

As of today (2024-06-24), Bioteque's share price is NT$129.00. Bioteque's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NT$6.90. Therefore, Bioteque's PE Ratio for today is 18.70.

As of today (2024-06-24), Bioteque's share price is NT$129.00. Bioteque's EPS without NRI for the trailing twelve months (TTM) ended in was NT$6.90. Therefore, Bioteque's PE Ratio without NRI for today is 18.70.

During the past 13 years, Bioteque's highest PE Ratio without NRI was 36.24. The lowest was 12.70. And the median was 19.96.


Bioteque Price-to-Owner-Earnings Historical Data

The historical data trend for Bioteque's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioteque Price-to-Owner-Earnings Chart

Bioteque Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.05 16.88 25.98 23.69 19.89

Bioteque Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.83 24.71 16.62 19.89 21.42

Competitive Comparison of Bioteque's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Bioteque's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Bioteque's Price-to-Owner-Earnings falls into.



Bioteque Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Bioteque's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=129.00/5.86
=22.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioteque  (ROCO:4107) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Bioteque Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Bioteque's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioteque (ROCO:4107) Business Description

Traded in Other Exchanges
N/A
Address
Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is a Manufacturing, trading, and seller of medical equipment and instruments and Reinvestment and monopoly investment in the securities business. The company operates in three different segments. 1. Segment A: manufacturing medical disposables for hemodialysis use, and selling them to global dealers and retailers. 2. Segment B: manufacturing and selling catheters for healthcare and medical PVC IV bag to medical organizations. 3. Segment C: manufacturing and selling medical key components and inner catheters to the medical organization.

Bioteque (ROCO:4107) Headlines

No Headlines